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Abstract 
Recent genome-wide association studies demonstrated association of single 
nucleotide polymorphisms (SNPs) in the TNFAIP3 region at 6q23 with systemic lupus 
erythematosus (SLE) in European-American populations. In this study, we 
investigated whether SNPs in the TNFAIP3 region are associated with SLE also in a 
Japanese population. A case-control association study was performed on the SNPs 
rs13192841, rs2230926 and rs6922466 in 318 Japanese SLE patients and 444 
healthy controls. Association of rs2230926 G allele with SLE was replicated in 
Japanese (allelic association P=0.033, odds ratio [OR] 1.47, recessive model 
P=0.023, OR 8.52). The association was preferentially observed in the SLE patients 
with nephritis. When the TNFAIP3 mRNA levels of the HapMap samples were 
examined using GENEVAR database, presence of TNFAIP3 rs2230926 G allele was 
associated with lower mRNA expression of TNFAIP3 (P=0.013). These results 
indicated that TNFAIP3 is a susceptibility gene to SLE both in the Caucasian and 
Asian populations. 
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Introduction 
Nuclear factor-κB (NF-κB) is a transcription factor that regulates expression of various 
genes including pro-inflammatory cytokines. TNFAIP3 (tumor necrosis factor 
alpha-induced protein 3) gene codes for A20, a ubiquitin-modifying protein required to 
inhibit NF-κB activation by several signaling pathways including TNF and Toll-like 
receptors [1]. TNFAIP3 deficient mice exhibited multiple organ inflammation and 
damage involving kidneys and joints [2]. NF-κB induces expression of A20; thus, A20 
plays a role in a negative feedback mechanism in NF-κB pathway. 
The lupus phenotypes in Fcγ receptor IIb deficient mice were reduced by treatment 
with NF-κB inhibitors [3], suggesting a role of NF-κB activation in the pathogenesis of 
systemic lupus erythematosus (SLE). A recent study reported that A20 negatively 
regulates immunostimulatory effects of dendritic cells and attenuates antigen 
presentation [4]. Thus, reduced function of A20 may induce excessive activation of 
dendritic cells and leads to the loss of tolerance to self-antigens.  
Since a genome-wide association study (GWAS) conducted by the Wellcome Trust 
Case Control Consortium reported association of TNFAIP3 region single nucleotide 
polymorphisms (SNPs) with rheumatoid arthritis (RA) and Crohn's disease in 2007 [5], 
association of SNPs in the region surrounding TNFAIP3 at 6q23 has been reported in 
several autoimmune diseases. Association of the TNFAIP3 region has subsequently 
been replicated in RA [6, 7], and was also reported in SLE by two groups using GWAS 
[8, 9]. These observations implicated that TNFAIP3 may be a common susceptibility 
gene to multiple autoimmune diseases. 
Specifically, Musone et al. reported independent association of three SNPs in the 
TNFAIP3 region, rs13192841, rs2230926 and rs6922466, with SLE in a 
European-American population [8]. The SNP rs2230926 is located in the coding 
region of TNFAIP3 and introduces amino acid substitution of Phe to Cys at position 
127 in the ovarian tumor domain, which was suggested to participate in the inhibitory 
function of A20 through deubiquitination of adaptor proteins [1]. Cys127 allele product 
was modestly less effective in inhibiting NF-κB activation by TNF than Phe127 [8]. 
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Recently, an extensive meta-analysis and imputation study by Bates et al. [10] 
demonstrated that the strongest association was detected at an intron 2 SNP 
rs5029939, which was originally detected by Graham et al. [9], and was in tight 
linkage disequilibrium (LD) with rs2230926. They also showed that the carrier of the 
risk allele was at higher risk of developing nephritis and hematological manifestations 
[10]. SNPs rs13192841 and rs6922466 were mapped within 250kb upstream and 
downstream of the TNFAIP3 region, respectively. 
Recently, we demonstrated that IRF5 [11], STAT4 [12] and BLK [13] are associated 
with SLE not only in the Caucasians, but also in the Japanese. In this study, we 
carried out a case-control association study of the SNPs in the TNFAIP3 region to 
examine whether TNFAIP3 is involved in genetic predisposition to SLE also in 
Japanese. 
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Patients and Methods 
Patients and controls 
A case-control association study was conducted in 318 Japanese patients with SLE 
(19 males and 299 females, mean ± SD age 41.4 ± 13.5 years) and 444 healthy 
controls (219 males and 225 females, mean ± SD age 34.0 ± 9.9 years), recruited at 
the University of Tsukuba, Juntendo University and the University of Tokyo. All 
patients and healthy individuals were native Japanese living in the central part of the 
Japan. All patients met the criteria for SLE proposed by the American College of 
Rheumatology [14]. 
In addition to the originally recruited controls, genotype data of 934 Japanese healthy 
controls were retrieved from the “JSNP550typed” dataset in the JSNP DATABASE 
(http://snp.ims.u-tokyo.ac.jp/jsnp_gtype_access.html) and analyzed [15].  
This study was reviewed and approved by the research ethics committees of 
University of Tsukuba, Juntendo University and the University of Tokyo. Informed 
consent was provided by all donors. 
 
DNA samples 
Genomic DNA was extracted from peripheral blood leucocytes using QIAamp blood 
kit (QIAGEN, Hilden, Germany) and amplified using the GenomiPhi DNA Amplification 
Kit (Amersham Biosciences, Piscataway, NJ, USA), following the manufacturer’s 
instructions. Whole genome amplification products were used for genotyping. 
 
Genotyping 
Genotyping of SNPs was carried out using the TaqMan genotyping assay (Applied 
Biosystems, Foster City, CA), according to the manufacturer’s instructions. The 
TaqMan probes used in this study were as follows: Assay ID: C___1575524_10 
(rs13192841), C___7701116_10 (rs2230926), and C__29431844_10 (rs6922466). 
Amplification was performed in a 10µl reaction volume containing 5µl of TaqMan 
Genotyping Master Mix and 0.125ul of TaqMan genotyping assay mix using 7300 
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Real-Time PCR System (Applied Biosystems). Thermal cycling conditions consisted 
of initial denaturation at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 
60°C for 1 min. 
Genotyping of 934 controls in the “JSNP550typed” dataset was performed using the 
Illumina HumanHap550 BeadChip (Illumina, Inc., San Diego, CA ), as indicated in the 
JSNP DATABASE. 
 
Association of TNFAIP3 SNP with TNFAIP3 mRNA expression 
Association of TNFAIP3 rs2230926 genotype with TNFAIP3 mRNA expression was 
examined using the mRNA data from lymphoblastoid cell lines derived from 44 JPT 
(the Japanese in Tokyo, Japan) and 45 CHB (the Han Chinese in Beijing, China) 
HapMap individuals available from the database of the Gene Expression Variation 
(GENEVAR) project at the Wellcome Trust Sanger Institute 
(http://www.sanger.ac.uk/humgen/genevar/), as previously described [11]. Genotypes 
of rs2230926 in HapMap samples were available from HapMap database 
(http://www.hapmap.org/index.html.en). Because there was no subject with G/G 
genotype, mRNA levels of TNFAIP3 were compared between rs2230926 G/T (n=24) 
and T/T (n=65) subjects.  
 
Statistical analysis 
Association analyses were conducted by chi-square test using 2 x 2 contingency 
tables. When 1 or more of the variables in the contingency tables was 5 or less, 
Fisher’s exact test was employed. Because this study intended to examine whether 
the association of TNFAIP3 is replicated in Japanese, correction for multiple testing 
was not applied and the uncorrected P values are shown.  
Based on the allele frequencies in Japanese, the sample size of this study (318 
patients and 444 controls) had the power of 80% to detect association when the 
genotype relative risk is 1.55 (rs13192841), 1.65 (rs2230926) and 1.45 (rs6922466), 
respectively [16]. 
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To examine LD between the SNPs in the TNFAIP3 region, LD parameters (D’ and r2 ) 
were calculated using Haploview version 4.0 software (Broad Institute of MIT and 
Harvard, Cambridge, MA), based on data from the 444 healthy Japanese controls. 
Difference in the mRNA expression between the rs2230926 G/T and T/T subjects in 
the HapMap subjects was analyzed by unpaired Student’s t-test. 
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Results and Discussion 
To examine whether TNFAIP3 is associated with SLE in a Japanese population, an 
association study of rs13192841, rs2230926 and rs6922466 was conducted in 318 
Japanese patients with SLE and 444 healthy controls. As observed in Caucasians [8], 
LD was modest among the examined three SNPs in 444 healthy Japanese controls 
(r2: 0.00-0.11, D’: 0.04-0.40). On the other hand, the intron 2 SNP rs5029939, which 
showed the strongest association in the study of Bates et al. [10], was in strong LD 
with rs2230926 also in Japanese (HapMap JPT: r2=0.86, D’=1.0). None of the control 
genotypes were significantly deviated from Hardy-Weinberg equilibrium.  
The association of rs2230926 with SLE was replicated in the Japanese, while 
evidence for association of rs13192841 and rs6922466 was not detected (Table 1). To 
confirm our findings, the patients’ genotypes were also compared with the genotypes 
of 934 Japanese controls available from JSNP DATABASE. As shown in Table 1, 
rs2230926 G allele frequency was significantly increased in SLE patients compared 
with JSNP controls. On the other hand, association of rs13192841 and rs6922466 
was not detected, even when the JSNP controls were used for comparison. 
Because the minor allele frequency of rs6920220, previously shown to be associated 
both with RA and SLE in European-American populations [6, 7, 9], was only 0.006 in 
the HapMap JPT samples, association was not examined for this SNP. 
We next tested whether rs2230926 in TNFAIP3 was associated with the development 
of nephritis. Frequency of rs2230926 G allele was significantly increased in SLE with 
nephritis (12.2%) as compared with healthy controls (7.5%, P=0.010, OR 1.70, 95%CI 
1.13-2.56), while significant difference was not observed between SLE without 
nephritis (8.6%) and healthy controls (Table 2). This finding is in agreement with Bates 
et al., who demonstrated preferential association of TNFAIP3 with SLE patients with 
nephritis in Caucasians [10]. Bates et al. also reported association of TNFAIP3 with 
hematological manifestations [10]. We did not carry out this analysis, however, 
because more than 90% of our patients fulfilled ACR classification criteria for 
hematologic disorder, especially lymphopenia (1500/µl). 
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A previous study suggested that the product of the risk allele, rs2230926 G (Cys127), 
may be modestly less efficient in inhibiting TNF-induced NF-κB activity [8]. To gain 
more insight into the functional significance of rs2230926, association of TNFAIP3 
mRNA levels with genotype was evaluated using the HapMap JPT and CHB subjects. 
Data on the mRNA levels in B cell lines from HapMap samples were obtained from 
GENEVAR database (http://www.sanger.ac.uk/humgen/genevar/). As shown in Figure 
1, the levels of TNFAIP3 mRNA was decreased in carriers of the rs2230926 G allele 
(G/T subjects) as compared with non-carriers (T/T) (P=0.013). This finding is in 
agreement with a previous study which demonstrated that TNFAIP3 intronic SNP 
rs5029930, which is strong LD with rs2230926 G, was associated with lower 
expression of TNFAIP3 mRNA expression in peripheral mononuclear cells [17]. Thus, 
our findings suggested that the molecular mechanisms of association of TNFAIP3 
haplotype containing rs2230926 G and rs5029939 G may involve both the functional 
change caused by the amino acid substitution at the protein level and the reduced 
expression level of A20 protein. 
A GWAS of SLE in a Chinese Han population was very recently reported for the first 
time in non-Caucasian populations [18]. In the study, association of TNFAIP3 
rs2230926, but not rs13192841 and rs6922466, with SLE was demonstrated, which 
was consistent with our results in Japanese. Thus, taken together with previous 
observations, our study established TNFAIP3 as a susceptibility gene to SLE common 
to Caucasian and Asian populations. Of particular interest, both the GWAS in Chinese 
[18] and a large-scale study in Caucasians [19] identified association of TNFAIP3 
interacting protein 1 (TNIP1), which binds to A20 and is thought to inhibit NF-κB 
signaling. These findings underscore the crucial role of NF-κB regulation pathway in 
the genetic background of SLE in multiple populations. 
 
Conclusions 
The association of rs2230926 in the coding region of TNFAIP3 with SLE was 
replicated in a Japanese population. Our finding demonstrated that TNFAIP3 is a 
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susceptibility gene to SLE both in the Asian and Caucasian populations. 
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Table. 1 Association of the TNFAIP3 region SNPs with SLE in a Japanese population. 
 
 
Genotype 
n (%) 
Allele 
n (%) 
 vs. controls (n=444)  vs. JSNP controls (n=934) 
 
 Allelic association  Recessive model#  Allelic association  Recessive model# 
 P OR(95%CI)  P OR(95%CI)  P OR(95%CI)  P OR(95%CI) 
rs13192841 A/A G/A G/G A             
SLE 5(1.6) 64(20.1) 249(78.3) 74(11.6)  0.43 1.14(0.82-1.58)  0.29 2.35(0.58-9.51)  0.45 1.12(0.84-1.48)  0.36 1.64(0.55-4.88) 
controls 3(0.7) 86(19.4) 355(80.0) 92(10.4)   reference   reference       
JSNP 
controls* 9(1.0) 179(19.2) 745(79.8) 197(10.6)         reference   reference 
                 
rs2230926 G/G T/G T/T G             
SLE 6(1.9) 56(17.6) 256(80.5) 68(10.7)  0.033 1.47(1.03-2.09)  0.023 8.52(1.45-50.1)  6.2X10-4 1.17(1.26-2.33)  0.049 2.97(1.00-8.82) 
controls 1(0.2) 65(14.6) 378(85.1) 67(7.5)   reference   reference       
JSNP 
controls* 6(0.6) 110(11.8) 818(87.6) 122(6.5)         reference   reference 
                 
rs6922466 G/G A/G A/A G             
SLE 12(3.8) 86(27.0) 220(69.2) 110(17.3)  0.80 0.97(0.74-1.26)  0.97 0.99(0.46-2.09)  0.20 0.86(0.68-1.09)  0.40 0.76(0.40-1.45) 
controls 17(3.8) 124(27.9) 303(68.2) 158(17.8)   reference   reference       
JSNP 
controls* 46(4.9) 274(29.3) 614(65.7) 366(19.6)         reference   reference 
OR: odds ratio, 95%CI: confidence interval.  
* Genotype data of healthy Japanese individuals obtained from JSNP DATABASE. 
# Recessive model for the minor allele. 
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Table 2. Association of TNFAIP3 rs2230926 with presence or absence of nephritis. 
 
rs2230926 
Genotype  Allele  Allelic association  Recessive model*  Dominant model* 
G/G T/G T/T  G  P OR (95%CI)  P OR (95%CI)  P OR (95%CI) 
SLE               
with nephritis (n=168) 4(2.4) 33(19.6) 131(78.0)  41(12.2)  0.010 1.70(1.13-2.56)  0.022 10.8(1.85-63.2)  0.035 1.62(1.03-2.53) 
without nephritis (n=145) 2(1.4) 21(14.5) 122(84.1)  25(8.6)  0.55 1.16(0.72-1.87)  0.15 6.20(0.75-51.1)  0.77 1.08(0.64-1.81) 
Controls (n=444) 1(0.2) 65(14.6) 378(85.1)  67(7.5)   reference   reference   reference 
 
OR: odds ratio, 95%CI: confidence interval. Parentheses in the genotype and allele frequency columns indicate percentages. 
*Recessive and dominant models for the G allele. 
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Figure Legend 
Figure 1. Association of TNFAIP3 rs2230926 with mRNA levels of TNFAIP3. 
Because there was no subject with G/G genotype, TNFAIP3 mRNA levels were 
compared between rs2230926 G/T (n=24, mean ± SD: 12.0 ± 0.43) and T/T 
(n=65, mean ± SD: 12.2 ± 0.33) subjects by unpaired Student’s t-test. The 
mRNA levels were obtained from the mRNA expression profiling data in the B 
cell lines from the HapMap JPT and CHB subjects (GENEVAR database).  
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